awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q47176287-7DE9A5ED-F36F-4D57-97CC-09FBB569791D
Q47176287-7DE9A5ED-F36F-4D57-97CC-09FBB569791D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47176287-7DE9A5ED-F36F-4D57-97CC-09FBB569791D
Phase I trial of anti-GD2 monoclonal antibody hu3F8 plus GM-CSF: Impact of body weight, immunogenicity and anti-GD2 response on pharmacokinetics and survival.
P2860
Q47176287-7DE9A5ED-F36F-4D57-97CC-09FBB569791D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47176287-7DE9A5ED-F36F-4D57-97CC-09FBB569791D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
581594ee1a4744bde5a7906fe2e083e9dbcedcaa
P2860
Population pharmacokinetics-pharmacodynamics of alemtuzumab (Campath) in patients with chronic lymphocytic leukaemia and its link to treatment response